The impact of cannabinoids in Schizophrenia

a systematic review

Autores

  • Ana Pina Águas UCIBIO – Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313, Porto, Portugal. Associate Laboratory i4HB – Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
  • Félix Carvalho UCIBIO – Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313, Porto, Portugal. Associate Laboratory i4HB – Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
  • Helena Carmo UCIBIO – Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313, Porto, Portugal. Associate Laboratory i4HB – Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
  • Maria João Valente National Food Institute, Technical University of Denmark, 2800, Kongens Lyngby, Copenhagen.
  • Diana Dias da Silva UCIBIO – Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313, Porto, Portugal. Associate Laboratory i4HB – Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal. TOXRUN – Toxicology Research Unit, University Institute of Health Sciences, CESPU, 4585-116 Gandra PRD, Portugal.

DOI:

https://doi.org/10.51126/revsalus.v4iSup.397

Palavras-chave:

cannabis use disorder, synthetic cannabinoids, phytocannabinoids, tetrahydrocannabinol (THC), Mental health

Downloads

Os dados de download ainda não estão disponíveis.

Downloads

Publicado

2022-04-06

Edição

Vol. 4 N.º Sup (2022): Suplemento da RevSALUS - Revista Científica Internacional da RACS

Secção

Pósteres

Licença

Creative Commons License

Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição-NãoComercial-SemDerivações 4.0.

You are free to:
Share — copy and redistribute the material in any medium or format;
Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Como Citar

The impact of cannabinoids in Schizophrenia: a systematic review. (2022). RevSALUS - Revista Científica Internacional Da Rede Académica Das Ciências Da Saúde Da Lusofonia, 4(Sup), 164-165. https://doi.org/10.51126/revsalus.v4iSup.397

Artigos mais lidos do(s) mesmo(s) autor(es)

1 2 3 > >>